193 top medical experts on Neonatal-onset citrullinemia type 2 across 11 countries and 3 U.S. states, including 10 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neonatal-onset citrullinemia type 2: A mild subtype of citrin deficiency characterized clinically by low birth weight, failure to thrive, transient intrahepatic cholestasis, multiple aminoacidemia, galactosemia, hypoproteinemia, hepatomegaly, decreased coagulation factors, hemolytic anemia, variable but mostly mild liver dysfunction, and hypoglycemia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations
  4. Synonyms: caused by Citrin Deficiency Neonatal Intrahepatic Cholestasis,  Neonatal-Onset Type II Citrullinemia,  NICCD,  Neonatal intrahepatic cholestasis caused by citrin deficiency,  Neonatal-onset citrullinemia type II


  

        

                    


    Computing Expert Listing ...